Concepedia

Chester F. Turk

CF

Statistics

Publications

12

Citations

623

H-Index

11

Active since

1963

Affiliations

Bristol-Myers Squibb (United States)(Current)

Chester F. Turk is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and structure-activity relationships.

Publications per year

1963–1992

12

Publications

12

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

John Krapcho, Chester F. Turk, David W. Cushman et al. · Journal of Medicinal Chemistry · 1988 · 163 citations · Full text

, , +15

Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-one and Related Compounds. II. A New Class of Antidepressants<sup>1</sup>

John Krapcho, Chester F. Turk · Journal of Medicinal Chemistry · 1966 · 79 citations

, , +9

Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones and 3,4-Dihydro-2-phenyl-(2H)-1,6-benzothiazocin-5(6H)-ones

John Krapcho, Ervin R. Spitzmiller, Chester F. Turk · Journal of Medicinal Chemistry · 1963 · 72 citations

, , +8

Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

David Floyd, S. David Kimball, John Krapcho et al. · Journal of Medicinal Chemistry · 1992 · 68 citations

, , +9

Syntheses and pharmacological activity of compounds related to the antidepressant, 5-(2-dimethylaminoethyl)-2,3-di-hydro-2-phenyl-1,5-benzothiazepin-4(5H)-one (thiazesim). III

John Krapcho, Chester F. Turk, Joseph J. Piala · Journal of Medicinal Chemistry · 1968 · 55 citations

, , +7

1–5 of 12